Brinton Pharma appoints Sathya Narayanan as CEO – India Cluster & JPAC
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
The drug also showed a manageable safety profile, with just 6.4% of patients stopping treatment due to side effects. No new safety concerns emerged
The trial will enroll up to 42 patients in Finland across four cohorts
The FDA also noted that current prescribing information for GLP-1 RAs already includes warnings about the risk of suicidal thoughts
The approval follows robust data from the SWIFT and ANCHOR Phase III trials
Subscribe To Our Newsletter & Stay Updated